Literature DB >> 635458

Evidence for excessive absorption of oxalate by the colon in enteric hyperoxaluria.

R Modigliani, D Labayle, C Aymes, R Denvil.   

Abstract

This work was designed to investigate the site of oxalate hyperabsorption in malabsorption syndromes. 1) Urinary oxalate excretion was measured in 27 patients with ileal resection (IR) and steatorrhea. Mean urinary oxalate excretion was high in 13 patients with IR and intact colon and in 9 subjects with IR and right hemicolectomy (90.2 +/- 11.9 and 108 +/- 18.6 mg per 24 hours; mean +/- S.E.M.), whereas it was normal in 5 patients with IR and ileostomy (21.9 +/- 4.4 mg per 24 hours). Steatorrhea was similar in the three groups. 2) On one patient of the last group in whom the colon had not been removed initially but excluded closure of the ileostomy resulted in the development of frank hyperoxaluria. 3) Intracolonic perfusion of calcium (1.93 g per day) abolished or greatly reduced the hyperoxaluria in 3 patients. These results indicate that the colon is the major site of oxalate hyperabsorption, and the right colon is not necessary for the development of hyperoxaluria in malabsorption syndromes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 635458     DOI: 10.3109/00365527809181746

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  13 in total

1.  Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation.

Authors:  John C Lieske; William J Tremaine; Claudio De Simone; Helen M O'Connor; Xujian Li; Eric J Bergstralh; David S Goldfarb
Journal:  Kidney Int       Date:  2010-08-25       Impact factor: 10.612

2.  Intestinal oxalate absorption in patients with continent urinary diversion.

Authors:  Gerd E von Unruh; Friederike B Ernst; Matthias E Schmidt; Gabriel Steiner; Albrecht Hesse; Stefan C Müller
Journal:  World J Urol       Date:  2005-11-09       Impact factor: 4.226

3.  Nephrolithiasis and nephrocalcinosis in rats with small bowel resection.

Authors:  R Corey O'Connor; Elaine M Worcester; Andrew P Evan; Shane Meehan; Dimitri Kuznetsov; Brett Laven; Andre' J Sommer; Sharon B Bledsoe; Joan H Parks; Fredric L Coe; Marc Grynpas; Glenn S Gerber
Journal:  Urol Res       Date:  2005-05

4.  Oxalate nephropathy associated with chronic pancreatitis.

Authors:  Claire Cartery; Stanislas Faguer; Alexandre Karras; Olivier Cointault; Louis Buscail; Anne Modesto; David Ribes; Lionel Rostaing; Dominique Chauveau; Patrick Giraud
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

5.  Probiotic-induced reduction of gastrointestinal oxalate absorption in healthy subjects.

Authors:  Joseph Okombo; Michael Liebman
Journal:  Urol Res       Date:  2010-03-12

Review 6.  Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease.

Authors:  Robert H Glew; Yijuan Sun; Bruce L Horowitz; Konstantin N Konstantinov; Marc Barry; Joanna R Fair; Larry Massie; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2014-11-06

7.  Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery.

Authors:  Rajiv Kumar; John C Lieske; Maria L Collazo-Clavell; Michael G Sarr; Ellen R Olson; Terri J Vrtiska; Eric J Bergstralh; Xujian Li
Journal:  Surgery       Date:  2011-02-05       Impact factor: 3.982

8.  Use of sevelamer hydrochloride as an oxalate binder.

Authors:  John C Lieske; Cynthia Regnier; John J Dillon
Journal:  J Urol       Date:  2008-03-04       Impact factor: 7.450

9.  Nephrolithiasis after bariatric surgery for obesity.

Authors:  John C Lieske; Rajiv Kumar; Maria L Collazo-Clavell
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

Review 10.  The management of patients with enteric hyperoxaluria.

Authors:  John R Asplin
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.